Loading company…
ID 400111295 · FY 2018–2024 · 7 years
კომპანიის ძირითად საქმიანობას წარმოადგენს ერთჯერადი მოხმარების სამედიცინო საქოლნის, სამედიცინო ხელსაწყოების და სამედიცინო აპარატურის რეალიზაცია, ასევე სერვისული მომსახურების გაწევა.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 27.6% | 25.6% | 24.8% | 28.9% | 24.7% | 29.3% | 42.1% |
| EBITDA Margin | 10.7% | 11.1% | 6.2% | 19.3% | 13.1% | 4.9% | 20.2% |
| EBITDAR | 554 | 419 | 243 | 1,538 | 865 | 357 | 925 |
| EBITDAR Margin | 11.0% | 11.6% | 6.7% | 19.5% | 13.5% | 5.4% | 20.9% |
| EBIT Margin | 10.7% | 11.1% | 6.2% | 19.3% | 13.1% | 4.9% | 20.2% |
| Net Profit Margin | 16.0% | 11.2% | 6.9% | 17.9% | 19.4% | 4.9% | 19.7% |
| Operating Expense % of Sales | 16.8% | 14.5% | 18.6% | 9.6% | 11.6% | 24.5% | 21.9% |
| Returns | |||||||
| Return on Assets (ROA) | 119.1% | 30.1% | 38.6% | 62.9% | 31.6% | 7.1% | 14.5% |
| Return on Equity (ROE) | 182.4% | 84.6% | 49.0% | 86.3% | 54.0% | 13.3% | 40.4% |
| ROIC [EBIT / Invested Capital] | 585.3% | 183.7% | 60.7% | 160.3% | 72.5% | 17.9% | N/A |
| Leverage & liquidity | |||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 65.3% | 35.6% | 78.8% | 73.0% | 58.5% | 53.2% | 36.0% |
| Net Debt | -349 | -258 | -148 | -685 | -1,140 | -624 | -3,502 |
| Cash & Equivalents | 349 | 258 | 148 | 685 | 1,140 | 624 | 3,502 |
| Total Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Efficiency & working capital | |||||||
| Inventory Turnover | N/A | 7.65x | 8.88x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | 47.7 | 41.1 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 91.27x | 5.54x | 35.29x | 7.14x | 7.38x | 3.60x | 7.89x |
| Days Sales Outstanding (DSO) | 4.0 | 65.9 | 10.3 | 51.1 | 49.5 | 101.5 | 46.3 |
| Payables Turnover | 15.49x | 3.11x | 19.66x | 9.27x | 2.96x | 2.20x | 0.67x |
| Days Payable Outstanding (DPO) | 23.6 | 117.3 | 18.6 | 39.4 | 123.2 | 166.0 | 547.8 |
| Cash Conversion Cycle | -19.6 days | -3.7 days | 32.9 days | 11.8 days | -73.7 days | -64.6 days | -501.6 days |
| Asset Turnover | 7.43x | 2.69x | 5.55x | 3.53x | 1.63x | 1.46x | 0.74x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | N/A | 604 | 409 | 1,541 | 1,367 | 3,975 | 7,146 |
| Free Cash Flow (OCF − Capex proxy) | N/A | 600 | 398 | 1,532 | 1,304 | 3,906 | 7,145 |
| Cash Conversion (OCF / EBITDA) | N/A | 151.2% | 182.2% | 101.5% | 162.5% | 1229.5% | 800.9% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).